glp-1 drugs zepbound Eli Lilly's Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head Test LOSING GLP-1 aCCESS

Electrophysiological analyses revealed that exendin 939 binds to the extracellular side of TRPV1, functioning as a noncompetitive inhibitor of CAP

Resistance Exercise Progressive resistance training (lifting weights, using resistance bands, or performing bodyweight exercises that progressively challenge the musculature) is the most effective stimulus for lean mass preservation and growth

Ozempic and Wegovy contain the same active ingredient (semaglutide), but they are approved for different uses and are packaged in different doses, as TODAY.com explained previously

Obesity, 18 (4), 750756

Measuring deuterium enrichment of glucose hydrogen atoms by gas chromatography/mass spectrometry

Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage